glp-1 agonist weight loss mechanism Frontiers GLP-1RAs Reduce External Eating Behavior

doi: 10.1002/jnr.23181 174 McCleanPLGaultVAHarriottPHolscherC

Hong B, Lee H, Choi A, Kim WJ, Cho YM, Yon DK, et al

This paper adds to growing evidence that GLP-1 receptor agonists may have an oncologic impact by improving metabolic health, said Paunel Vukasinov, MD, a dual board certified internist and obesity medicine specialist at Medical Offices of Manhattan

Demonstrating efficacy in obesity-related comorbidities will be paramount in order to achieve reimbursement in Europe, yet it will take time for trials focused on these co-morbidities to translate into label expansion and revenues

Diabetes 2005

Daily injections require more consistency in routine